 In an openly conciliatory move, the “EBM+” group of philosophers and clinicians (see  Other Internet Sources),  offers a defense of the view that mainstream EBM has erred by essentially relegating mechanistic evidence, such as EGCG having anti-cancer chemical properties, to a subsidiary role (B. Clarke et al. 2014).